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Background
Bicuspid aortic valves (BAV) are associated with higher
incidence of aortopathy such as aortic dilatation, dissec-
tion, and aortic valve stenosis. Recent 4D flow MRI stu-
dies have provided evidence that BAV aortopathy is
associated with specific hemodynamic abnormalities and
increased wall shear stress (WSS) which is thought to
alter aortic endothelial cell function and induce remo-
deling and dilatation. Pharmacologic management of
BAV is currently debated. It has been hypothesized that
blood pressure control using medical therapy can
decrease or reduce the rate of change to central arterial
pressure and thus reduce wall forces such as wall shear
stress (WSS) on the aneurysmal segment of the aorta to
prevent aortic remodeling and dilatation. However, in-
vivo studies investigating the effect of cardiac medica-
tions on aortic WSS in BAV patients are lacking. In this
longitudinal follow-up 4D flow MRI study, the effects of
Beta blockers (BB), Angiotensin converting enzyme inhi-
bitors (ACEI), and Angiotensin II Receptor Blockers
(ARB) on the aortic WSS was investigated using 4D
Flow MRI.
Methods
13 patients referred for MRI to assess aortic valve func-
tion and morphology were retrospectively included. MRI
included 4D flow MRI (time resolved 3D PC MRI with
3-directional velocity encoding) to assess in vivo blood
flow velocities with full volumetric coverage of the thor-
acic aorta. Each participant underwent baseline and a
6-19 (10.7 ± 3.5 months) month follow-up cardiac MRI
including 4D flow MRI. The first group (“Drug+” n = 5)
underwent a baseline scan without ARB, ACEI, or BB
and was prescribed one such medication prior to the
follow-up scan. The second group (“Drug-” n = 8) was
prescribed no such medical therapy for both study visits.
Data analysis included the 3D segmentation of the thor-
acic aorta (MIMICS, Materlise, Belgium) and calculation
of systolic 3D WSS along the entire aortic wall from 4D
flow velocity acquisition as shown in Figure 1, panel A
and B. Mean and median WSS was quantified in the
proximal ascending aorta, mid ascending aorta, proximal
arch, mid arch, and descending aorta.
Results
Summarized in Table 1, the prescription of medical
therapy did not result in significant changes in global
(entire aorta, table 1) or regional (aortic segments, tables
2 and 3) WSS. Changes in mean global WSS were small
and similar for the Drug+ group 0.59 ± 0.07 Pa vs.
0.56 ± 0.08 Pa, -4.9% differences, p = 0.33) and the
Drug- group (0.69 ± 0.13 Pa vs. 0.66 ± 0.15 Pa, 8.5% dif-
ferences, p = 0.421).
Conclusions
Overall there was a small non-significant 4.9% decrease
in mean global WSS from baseline in patients prescribed
ACEI, ARB, or BB. WSS was not statistically significant
between the two patient groups. Our findings suggest
that current medical therapy is not effective in changing
aortic hemodynamics and reducing systolic WSS.
Further investigation in larger cohorts is necessary to
confirm these findings and determine if WSS measure-
ments can be used to evaluate the effectiveness of drug
therapy.
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Figure 1 A: global WSS map of thoracic aorta of subject not on cardiac medication. B: global WSS map of thoracic aorta of subject
prescribed BB prior to follow-up. Table 1: Global WSS findings. Table 2: Changes in raw WSS from baseline to follow-up. Table 3: Percent change
from baseline. AAo: Ascending aorta; Dao: Descending Aorta.
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